# A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail

> **NCT02267356** · PHASE2 · COMPLETED · sponsor: **Viamet** · enrollment: 259 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** VT-1161
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02267356
- **Lead sponsor:** Viamet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-17
- **Primary completion:** 2016-10-18
- **Final completion:** 2017-07-07
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02267356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02267356, "A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02267356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*